Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine Low dOse Evaluation on Morphine Consumption in Traumatic Patient


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04833816

Organisation Name: Assistance Publique Hopitaux De Marseille

Overal Status: Not yet recruiting

Start Date: May 1, 2021

Last Update: April 6, 2021

Lead Sponsor: Assistance Publique Hopitaux De Marseille

Brief Summary: The aim of this study is to demonstrate a significant reduction of at least 25% in opioid consumption at 48 hours of management of severe trauma, while demonstrating non-inferiority in terms of analgesia, in a group of patients receiving a continuous infusion of low dose ketamine compared to a placebo group.

Conditions:
  • Traumatic Injury


Total execution time in seconds: 0.18606805801392